Zobrazeno 1 - 10
of 11
pro vyhledávání: '"T P, Suthar"'
Autor:
T. I Trivedi, T. P. Suthar, Devendra D. Patel, Hemangini H. Vora, N. Ghosh, P. R. Chikhlikar, Bhatavdekar Jm, N. G. Shah
Publikováno v:
European Journal of Surgical Oncology (EJSO). 26:540-547
Aims: The aim of this study was to evaluate the prognostic value of pre-operative prolactin (PRL) in conjunction with established prognosticators, and the risk of disease relapse in patients with early and advanced breast cancer. To confirm the hypot
Autor:
D D, Patel, J M, Bhatavdekar, P R, Chikhlikar, Y V, Patel, N G, Shah, N, Ghosh, T P, Suthar, D B, Balar
Publikováno v:
Journal of surgical oncology. 65(2)
The purpose of this retrospective study was to test whether the expression of p53, nm23, and bcl-2 in T3-4N1M0 oesophageal carcinoma is associated with patient survival.Immunohistochemical localisation of p53, nm23, and bcl-2 was performed on formali
Autor:
D D, Patel, J M, Bhatavdekar, P R, Chikhlikar, N, Ghosh, T P, Suthar, N G, Shah, R H, Mehta, D B, Balar
Publikováno v:
Journal of surgical oncology. 62(2)
The purpose of this study was to investigate a prognostic indicator that can differentiate node negative breast cancer patients (N = 39, T2N0M0) with high risk and low risk for the development of recurrence or metastases. Preoperative plasma prolacti
Autor:
Bhatavdekar Jm, N. G. Shah, Devendra D. Patel, Karelia Nh, Balar Db, N. Ghosh, Hemangini H. Vora, T. P. Suthar
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 21(1)
Prognostic value of IGF-1 receptors (IGF-1R) was evaluated and compared with circulating prolactin (PRL) in 59 patients with Dukes B or C colon/rectal cancer. IGF-1R was estimated by radioligand binding assay and PRL was estimated by immunoradiometri
Autor:
J M, Bhatavdekar, D D, Patel, N H, Karelia, N G, Shah, N, Ghosh, H H, Vora, T P, Suthar, D B, Balar, S S, Doctor
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 20(2)
The antiestrogen tamoxifen (TAM) is an effective therapy for advanced breast cancer. However, its use is limited by the eventual development of acquired TAM resistance in many patients. There is now strong evidence to suggest that prolactin plays an
Autor:
D D, Patel, J M, Bhatavdekar, N, Ghosh, H H, Vora, N H, Karelia, N G, Shah, T P, Suthar, D B, Balar, C R, Trivedi
Publikováno v:
Cancer. 73(3)
Preoperative plasma prolactin and carcinoembryonic antigen (CEA) levels were assessed to monitor disease recurrence and to identify low-risk and high-risk patients with Dukes B or C colorectal cancer.Prolactin and CEA were estimated by radioimmunoass
Autor:
J M, Bhatavdekar, D D, Patel, P R, Chikhlikar, R H, Mehta, H H, Vora, N H, Karelia, N, Ghosh, N G, Shah, T P, Suthar, J P, Neema
Publikováno v:
Neoplasma. 41(2)
Levels of circulating peptide (FSH, LH, prolactin, ACTH, calcitonin, gastrin and insulin-like growth factor-1 [IGF-1]) and steroid (estradiol, progesterone, DHEA-S and testosterone) hormones were estimated by radioimmunoassay (RIA) and immunoradiomet
Publikováno v:
Neoplasma. 41(5)
Circulating epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I) were estimated in 58 patients with epithelial ovarian cancer and were correlated with clinically and biochemically important prognosticators. IGF-I levels were signifi
Autor:
J M, Bhatavdekar, D D, Patel, G V, Sherbet, D D, Giri, N H, Karelia, H H, Vora, N G, Shah, T P, Suthar, S P, Nadkarni, D B, Balar
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 19(5)
Having established prolactin to be an indicator of disease progression and hyperprolactinemia as an independent predictor of short term prognostication, we have in this report compared plasma prolactin with the expression of c erb B-2 oncoprotein, ER
Autor:
J M, Bhatavdekar, D D, Patel, N H, Karelia, T P, Suthar, N G, Shah, H H, Vora, N, Ghosh, S P, Nadkarni, D B, Balar
Publikováno v:
Neoplasma. 40(3)
Estrogen and progesterone receptors (ER and PR) were estimated in 129 synchronous (primary and metastatic lymph node) breast cancer tissues, of which 40% were premenopausal and 60% were postmenopausal. ER and PR accordance was seen in 68% and 70% pat